The net profit of the company stood at Rs 70.05 crore during the same period a year ago, said Biocon in a filing to the BSE on July 26, 2012.
The total income of the company grew by 30 per cent to Rs 576.68 crore during Q1 2012-13, compared with Rs 443.48 crore during the year ago period.
Commenting over the performance, Biocon's Chairman and MD, Kiran Mazumdar Shaw said, "I am pleased to report that we have seen strong performances across all our business verticals and this reflects the success of our segmented business model. I draw attention to our R&D investments that have increased 75 per cent year-on-year this quarter".
Shares of the company were trading at Rs 245 a piece, down 2.41 per cent on BSE at 1.50 pm IST.